Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v1-EN
Language English English
Date Updated 2017-05-10 2017-03-14
Drug Identification Number 02285061 02285061
Brand name TEVA-LISINOPRIL (TYPE P) TEVA-LISINOPRIL (TYPE P)
Common or Proper name LISINOPRIL P LISINOPRIL P
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LISINOPRIL LISINOPRIL
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-04-01 2017-04-01
Actual start date
Estimated end date 2017-04-27 2017-04-27
Actual end date 2017-05-04
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments